The latest ranking of China's medical equipment brand strength is released

On September 20, at the China Medical Equipment Innovation Products and Technology Exhibition, China Medical Equipment magazine officially released the 2023-2024 China Medical Equipment Brand Strength Research Report, and announced several "Medical Equipment Brand Strength Rankings", among which Shengnuo Medical, a subsidiary of Yingkang Life, was listed in the "2024 China Medical Equipment Brand Strength Top 100 Enterprises". The list is evaluated from five dimensions: technical research and development, quality reliability, service satisfaction, market influence, and consumer satisfaction. It involves a total of 24 mainstream medical equipment product lines, covering more than 500 brands.

(Shengnuo Medical, a subsidiary of Yingkang Life, is listed in the "2024 China Medical Equipment Brand Strength Top 100 Enterprises")
It is understood that the research report was created by China Medical Equipment Magazine, Guangdong Research Institute of New Biomaterials and High-end Medical Devices, and Beijing Smart Medical Technology Innovation Alliance, with the help of the "Good Medical Worker" APP, based on the "Medical Industry Expert Database Mother Database" and the high-end research institute database. The research report includes multiple lists: such as the 2024 China Medical Equipment Brand Strength Ranking, the 2024 Product Line Medical Equipment Brand Strength Ranking, the 2024 Dimensional Medical Equipment Brand Strength Ranking, the Provincial and Municipal Medical Equipment Brand Strength Ranking, and the Focus on China's Medical Equipment Strength Brands.
In terms of the scope of the survey, the report covers a total of 24 mainstream medical equipment product lines, covering more than 500 medical equipment brands, and more than 4,000 hospitals participated in the survey; in terms of the depth of the survey, it covers the entire life cycle of medical equipment, including early research and development, market promotion, product use, and after-sales service, and has designed five key evaluation dimensions: technical research and development, quality reliability, service satisfaction, market influence, and consumer satisfaction. It aims to scientifically demonstrate the brand strength and development potential of mainstream domestic medical equipment through in-depth and comprehensive statistical analysis, through real-world authoritative objective data + real subjective evaluation data of hospital departments.
In recent years, Yingkang Life has always adhered to the high-end, digital and global development strategy in the field of medical devices, and has insisted on technological innovation and digital transformation to provide users with smarter and more convenient services.
In terms of technological innovation, the company has developed the first digital breast machine DR and hydraulic high-pressure injector in China, and pioneered a self-contained infusion warming whip workstation and an enteral nutrition precision infusion system in the field of life support. In 2024, the Discovery D series of high-pressure injectors benchmarked against the world's first-class will be officially launched. It is the first to have a wireless design and is equipped with a full-scenario installation solution. It is at the leading level in China in terms of safety, convenience, and intelligence. So far, 19 members of the Radiology Branch of the Chinese Medical Association have used high-pressure infusion equipment and consumables, and more than 3,000 medical institutions have used precision infusion products in China.
In terms of digitalization, the company has launched the third-generation digital breast molybdenum target X-ray photography system. By integrating and innovating technologies such as three-dimensional tomography, breast AI intelligent analysis, and 5G cloud diagnosis, the lesion detection rate is as high as 93%, and the accuracy rate of benign and malignant is as high as 94%; the upgraded smart infusion scene service can realize the full process supervision of infusion nursing services, and has entered more than 100 hospitals.
At present, Yingkang Life's layout in the field of medical devices has covered four major scenarios: radiotherapy, life support, image enhancement and chronic disease treatment. It has served more than 600 tertiary hospitals and thousands of hospitals at all levels in China, as well as nearly 100 countries and regions around the world. In the future, Yingkang Life will continue to expand around key scenarios and key equipment for tumor pre-diagnosis and treatment, and promote the company's high-quality and sustainable development with users as the center and innovation as the driving force.